Revised. Amendments from Version 2
==================================

Compared to the previous version, the abstract has been extensively rewritten to include as many illustrative results as follows. We have also made it clearer that our opinion that introducing e-cigarettes should lead to a reduced risk of SRD is not based on primary data, but only on general considerations.  This does not now appear as a major conclusion tn the first paragraph of the discussion section.  The main text of the paper has also been modified in a few places to make the limitations of our work a bit clearer, and to improve the English in some places.

Introduction
============

Recent publications make it clear that, in youths, vaping (i.e., use of e-cigarettes) and cigarette smoking (subsequently referred to as "smoking") are strongly associated. In the U.S., for example, a survey of ninth and tenth grade students in Hawaii in 2014 ( [@ref-90]) revealed 195 ever-users of both products, 250 ever-vapers only, 37 ever-smokers only, and 820 never-users of either. From these data, the odds ratio (OR) relating ever-vaping to ever-smoking can be estimated as 17.3 (95% confidence interval (CI) 11.8--25.3). A strong association can also be seen for sixth to twelfth grade students in Texas in 2014 ( [@ref-16]), with an OR of 28.8 (25.0--33.1), as well as nationally in 2012 ( [@ref-23]), with an OR of 31.9 (27.6--36.8). Similarly strong relationships are reported also in Canada ( [@ref-3]), France ( [@ref-19]), Great Britain ( [@ref-25]), Poland ( [@ref-32]), and Korea ( [@ref-49]). Theoretically, this association may arise if vaping encourages smoking, if smoking encourages vaping, and/or if other factors link to use of both products.

Concern that vaping may encourage subsequent smoking, the so-called "gateway" effect, was fuelled by a recent paper by [@ref-77]. In this manuscript, the authors combined epidemiological evidence from nine U.S. cohort studies in young people that linked smoking initiation to previous vaping. Among baseline never-smokers, baseline ever-vaping strongly predicted smoking initiation within six to 18 months (OR 3.62, 95% CI 2.42--5.41) after adjusting for various predictors of initiation. Similarly, baseline past 30-day vaping predicted subsequent 30-day cigarette use (OR 4.28, 95% CI 2.52--7.27).

Based on these results and those from one additional study ( [@ref-36]), the National Academies Press on the Public Health Consequences of E-Cigarettes ( [@ref-61]) recently concluded that "there is substantial evidence that e-cigarette use increases risk of ever using combustible tobacco cigarettes among youth and young adults, noting that the relevant studies had adjusted for "a wide range of covariates" and considering that it was "unlikely that confounding entirely accounts for the association because reductions in estimates of association from unadjusted to adjusted models were not consistently observed in the literature."

Methods
=======

This review considers various methodological aspects of the gateway issue in youths.

Search parameters
-----------------

First, based on PubMed searches carried out at intervals starting in May 2017 on "ecigarettes" or "e-cigarettes" or "e-cigs" or "electronic cigarette" or "ecigarette" or "e-cigarette", we identified papers and reviews that presented results from prospective studies of young people relating to the gateway effect. Further publications were also sought from reference lists of selected papers and reviews. For this review, we also considered studies that provided data on trends over time in cigarette smoking by youths in relation to e-cigarette use, and information on initiation of smoking and e-cigarette smoking by youths relevant to the gateway effect.

A list of factors other than e-cigarette use that are associated with the initiation of cigarette smoking was obtained from [@ref-85] and from a separate ongoing review on determinants of smoking initiation which aims to present meta-analyses of associations between initiation of cigarette smoking and the various other factors. This identified references using an Embase search in April 2017 with the following search string:

'smoking'/de OR 'smoking' AND ('initiation'/de OR 'initiation') AND ('prevalence'/de OR 'prevalence' OR 'incidence'/de OR 'incidence' OR 'proportion' OR 'age'/de OR 'age' OR 'dual use' OR 'combined use' OR 'psychosocial'/de OR 'psychosocial' OR 'beliefs'/de OR 'beliefs' OR 'attitudes'/de OR 'attitudes' OR 'perceptions'/de OR 'perceptions' OR 'opinions' OR 'acceptance'/de OR 'acceptance' OR 'predictors'/de OR 'predictors' OR 'friend'/de OR 'friend' OR 'family'/de OR 'family' OR 'parent'/de OR 'parent' OR 'propensity score'/de OR 'propensity score') AND \[humans\]/lim AND \[english\]/lim AND (\[embase\]/lim OR \[medline\]/lim)

For the current paper, we only use the results from this search to list those factors shown in one or more studies to strongly associate with initiation of smoking, and to consider the extent to which the identified gateway studies take these factors into account.

Analysis of search results
--------------------------

In addition, separate sheets of an Excel Program ( [@ref-50]) were developed to: (a)estimate the effects of omission of a confounding variable, or misclassification of it, under a range of assumptions on the association between vaping and subsequent initiation of smoking, and to(b)determine, again under various assumptions, how the prevalence of smoking might be affected by any true gateway effect of vaping.

Full details are given in, respectively, Additional Files 2 and 3 ( [@ref-50]). Both sheets are used to provide illustrative examples of how the effects depend on the parameter values assumed.

In the first sheet, the use may determine how the observed gateway effect depends on the following eight parameters: The proportion of vapers in never smokers (P ~1~)The proportion with a particular smoking predictor present in never smokers (P ~2~)The odds ratio relating vaping to the smoking predictor (K)The probability of initiating smoking during follow-up in those who neither smoke nor have the predictor (P ~A~)The odds ratio for initiating smoking during follow-up associated with vaping - the true gateway effect (G ~E~)The odds ratio for initiating smoking during follow-up associated with the smoking predictor - the true smoking predictor effect (G ~P~)The proportion with the predictor who are misclassified as not having it (M ~1~), andThe proportion without the predictor who are misclassified as having it (M ~2~)

P ~1~, P ~2~ and K allow define the baseline population of N never smokers to be subdivided in a 2 × 2 table according to presence or absence of e-cigarettes and of the smoking predictor. P ~A~, G ~E~ and G ~P~ allow determination of the distribution of the population after a single follow-up period. M ~1~ and M ~2~ are misclassification rates of the predictor.

In the second sheet, the program considers individuals, divided into five equal strata, who initially are all never users of either cigarettes or e-cigarettes. The probability of initiating smoking or vaping increases progressively over the strata, the strata being intended to represent sets of individuals with an increasing susceptibility to tobacco. Over five time intervals, the individuals may transfer to four other groups: current vapers only, current smokers only, current dual users and former users (those who have used one or both products but do not currently use either). Users may modify the values of seven parameters: The initiation rate of vaping in the first stratum (P ~1~)The relative odds of initiation for successive strata (R ~1~)The relative odds of initiation with smoking compared to vaping (R ~2~)The relative odds of quitting compared to initiation (R ~3~)The relative odds of re-initiation compared to initiation (R ~4~)The relative odds of initiating smoking for vapers compared to tobacco never-users (G ~1~)The relative odds of quitting smoking for dual users compared to smokers only (G ~2~)

Note that R ~3~ and R ~4~ are each taken to be applicable to either product.

Lastly, the review also includes an analysis of trends in e-cigarette and smoking prevalence in youths based on national surveys which provided annual information over a period of at least 10 years. We identified four surveys from the U.S., the Youth Risk Behavior Survey (YRBS: available from <https://www.cdc.gov/healthyyouth/data/yrbs/index.htm>), the National Youth Tobacco Survey (NYTS: available from <https://www.cdc.gov/tobacco/data_statistics/surveys/nyts/index.htm>), the Monitoring the Future study (MTF: available from <https://www.icpsr.umich.edu/icpsrweb/NAHDAP/series/35>), and the National Survey on Drug Use and Health (NSDUH: available from <https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health>). We also identified two surveys from the UK, the Smokefree Youth Survey in Great Britain (SYSGB: available from <http://ash.org.uk/download/use-of-electronic-cigarettes-among-children-in-great-britain/>) and the Office for National Statistics (ONS: available from <https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/drugusealcoholandsmoking/datasets/ecigaretteuseingreatbritain>). All six databases were accessed on 16 Oct 2017.

Based on linear regression of log ~e~ (p/(1−p)) on year, where p is the prevalence of smoking, observed prevalences in the years 2014--2016 (a period where the advent of e-cigarettes might have had a measurable effect on smoking prevalence if an important gateway effect existed) was compared with those expected based on the trend in those previous years for which results were available.

Results
=======

Evidence relating vaping in youths to subsequent initiation of cigarette smoking
--------------------------------------------------------------------------------

From the literature search, we identified a key systematic review and meta-analysis by [@ref-77] on the association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adult. [Table 1](#T1){ref-type="table"} provides details of the nine U.S. studies analyzed by [@ref-77]. A total of five studies, conducted with participants with a maximum age of 24--30 years old, collected information using internet-based surveys. The four other studies, involving participants aged less than 20 years old were based on self-completed questionnaires. The follow-up period was 6 months in one study ( [@ref-39]), 1 year in five studies ( [@ref-52]; [@ref-69]; [@ref-79]; [@ref-84]; [@ref-90]), and 13 to 18 months in the other three studies ( [@ref-7]; [@ref-60]; [@ref-68]). While most of the studies (marked with an A in [Table 1](#T1){ref-type="table"}) concerned ever- and never-use, two studies (marked with a B) considered current and noncurrent use. While the ORs marked B are less informative as they relate partly to relapse rates, they have been included for completeness.

###### Association between vaping at baseline and subsequent smoking among youths.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source ^[a](#FN1){ref-type="other"}^   Location           Sample\                              Age/grade   Follow-up\        Odds\                                 Unadjusted OR\                           Adjusted OR\
                                                            size ^[b](#FN1){ref-type="other"}^               period (months)   ratio ^[c](#FN1){ref-type="other"}^   (95% CI) ^[d](#FN1){ref-type="other"}^   (95% CI) ^[d](#FN1){ref-type="other"}^
  -------------------------------------- ------------------ ------------------------------------ ----------- ----------------- ------------------------------------- ---------------------------------------- ----------------------------------------
  [@ref-52]                              USA, Los Angeles   2558                                 14          12                A                                     7.78 (6.15--9.84)                        1.75 (1.10--2.78)

  [@ref-69]                              USA, National      694                                  16--26      12                A                                     5.66 (1.99--16.07)                       8.30 (1.19--58.00)

  [@ref-7]\                              USA, Southern\     298                                  16--18      16                A                                     5.76 (3.12--10.66)                       6.17 (3.29--11.57)
  [@ref-7]                               California                                                                                                                                                           

  [@ref-68]                              USA, National      1506                                 18--30      18                A                                     6.06 (2.15--17.10)                       8.80 (2.37--32.69)

  [@ref-60]                              USA, National      246                                  17--20      13                A                                     6.23 (1.57--24.63)                       4.78 (1.91--11.96)

  [@ref-79]                              USA, National      2316                                 18--25      12                A                                     3.50 (2.41--5.09)                        3.37 (1.91--5.54)

  [@ref-90]                              USA, Hawaii        1141                                 14--16      12                A                                     4.25 (2.74--6.61)                        2.87 (2.03--4.05)

  [@ref-39]                              USA, National      1028                                 13--25      6                 B                                     11.18 (5.41--23.13)                      5.43 (2.59--11.58)

  [@ref-84]                              USA, Los Angeles   1056                                 22--24      12                B                                     4.71 (2.27--9.77)                        3.32 (1.55--7.11)

  Other studies                                                                                                                                                                                               

  [@ref-9]                               UK, Scotland       2125                                 11--18      12                A                                     4.62 (3.34--6.38)                        2.42 (1.63--3.60)

  [@ref-14]                              UK, England        1726                                 13--14      12                A                                     5.38 (4.02--7.22)                        4.06 (2.94--5.60)

  [@ref-55]                              USA, Texas         2558                                 18--25      18                A                                     2.73 (2.11--3.54)                        1.36 (1.01--1.83)

  [@ref-86]                              USA, National      10384                                12--17      12                A                                     3.50 (2.48--4.94)                        2.53 (1.80--3.56)

  [@ref-36]                              Canada, 2 states   19310                                14--18      12                A                                     4.81 (3.90--5.94)                        2.12 (1.68--2.66)

  [@ref-56]                              Mexico, 3 cities   4695                                 12--13      20                A                                     1.82 (1.54--2.14)                        1.40 (1.22--1.60)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Two studies ( [@ref-39]; [@ref-68]) were reported only as abstracts, but fuller details were supplied to Soneji *et al*. for their meta-analyses. ^b^Of never- (or noncurrent) smokers at baseline. ^c^A = Odds of smoking initiation, among never-smokers at baseline, for ever- compared with never-vapers at baseline. B = Odds of smoking at baseline, among noncurrent smokers at baseline, for current compared with noncurrent vapers at baseline. ^d^ORs for U.S. studies as given by Soneji *et al*. ORs for U.K. studies come from the source, except that the unadjusted estimates for Best *et al*. and Loukas *et al*. were estimated from data given.

Each study found that baseline vaping significantly predicted subsequent smoking, regardless of covariate adjustment. Adjusted ORs were lower than unadjusted ORs in six studies, particularly in two ( [@ref-39]; [@ref-52]). However, two studies ( [@ref-69]; [@ref-68]) showed a moderately increased OR after adjustment.

[Table 1](#T1){ref-type="table"} also includes results from six later studies cited in a recent review ( [@ref-31]): two from the U.S. ( [@ref-55]; [@ref-86]), two from the U.K. ( [@ref-9]; [@ref-14]), and one each from Canada ( [@ref-36]) and Mexico ( [@ref-55]). These results showed an association that reduced but remained significant after adjustment. Two further studies could not be included in [Table 1](#T1){ref-type="table"}, as they did not provide comparable results. One was a study on young adults in the Chicago area ( [@ref-75]) that used path analysis and concluded that "E-cigarette use was not significantly associated with later conventional smoking..." The other was a study in the Netherlands ( [@ref-82]) that reported a strong association after covariate adjustment but did not present unadjusted results for comparison.

There were an additional 15 publications ( [@ref-4]; [@ref-5]; [@ref-6]; [@ref-10]; [@ref-20]; [@ref-22]; [@ref-27]; [@ref-37]; [@ref-41]; [@ref-45]; [@ref-51]; [@ref-54]; [@ref-80]; [@ref-89]; [@ref-92]) identified in our searches as of possible relevance based on the abstract. However, none of these provided useful data for various reasons. These included studies which: were conducted in adults; predicted e-cigarette use rather than cigarette smoking; did not present results in a form allowing the gateway effect to be estimated; were superseded by later publications; concerned intent to smoke cigarettes and not actual smoking; or even did not consider e-cigarettes at all.

Association of smoking with other risk factors
----------------------------------------------

Initiation of smoking is long-established to be associated with various sociodemographic, environmental, and behavioral factors. Those identified by an authoritative source over 20 years ago ( [@ref-85]) include low education level ( [@ref-35]; [@ref-72]), internalizing/externalizing disorders ( [@ref-21]; [@ref-26]; [@ref-71]), outcome expectancies ( [@ref-6]; [@ref-76]), susceptibility to smoking ( [@ref-40]; [@ref-42]), conduct problems ( [@ref-17]; [@ref-74]), substance use ( [@ref-70]; [@ref-74]), risk-taking behaviour ( [@ref-15]; [@ref-17]), poor school performance ( [@ref-63]; [@ref-72]), anxiety ( [@ref-15]; [@ref-74]), household smoking ( [@ref-66]; [@ref-72]), peer smoking ( [@ref-6]; [@ref-66]), peer attitudes to smoking ( [@ref-6]; [@ref-18]), low self-esteem ( [@ref-17]; [@ref-87]), and other tobacco product use ( [@ref-7]; [@ref-43]). Currently available evidence reveals that many of these predictors consistently show a strong association with initiation, with reported ORs often exceeding 10. While these predictors are clearly not all independent, their number illustrates the difficulty in ensuring that gateway studies consider an adequate list. To avoid unfeasibly long questionnaires or huge studies, further work is needed to define an agreed minimum list of factors.

For the 15 studies included in [Table 1](#T1){ref-type="table"}, Additional File 1 ( [@ref-50]) describes in detail how these risk factors were taken into account. While standard demographics were generally considered, and smoking susceptibility, substance use, risk-taking behaviour, other tobacco use, parental education, family smoking, and peer smoking were considered in at least five studies, many other relevant factors were rarely considered. These include internalizing/externalizing disorders, outcome expectancies, school performance, anxiety, parental smoking, and peer attitudes to smoking. The studies vary in the number of factors accounted for, some ( [@ref-14]; [@ref-52]; [@ref-86]; [@ref-90]) considering more than 10 factors, others ( [@ref-60]; [@ref-84]) only five. As shown in Additional File 1 ( [@ref-50]), the questions used to assess these factors also varied considerably between studies.

Unfortunately, no study reported which factors contributed most to their adjustment. Thus, for example, [@ref-52] adjusted for the most factors and found that the unadjusted OR of 7.78 (6.15--9.84) reduced dramatically after adjustment to 1.75 (1.10--2.78); however, the authors did not clarify which factors mainly contributed to this reduction.

While the search terms we considered may not have been fully comprehensive, it is clear from the material considered that a wide range of risk factors are related to initiation of smoking and that many of them were considered rarely, if at all, in the gateway studies.

Bias in the estimated gateway effect due to failure to adjust for a relevant covariate -- simple confounding
------------------------------------------------------------------------------------------------------------

What effect might failure to adjust for a relevant predictor of smoking have on the estimated gateway effect observed between vaping and smoking? To attempt to gain insight into this question, we consider (using the first sheet of the Excel program we developed) a hypothetical baseline population of N never-smokers, of which P ~1~ vape, and P ~2~ have the smoking predictor. P ~1~ and P ~2~ are correlated, with an odds ratio of K. We assume that, during follow up, those who neither have smoked nor have the predictor have a probability of initiating smoking of P ~A~ and that the odds of smoking initiation are independently increased by G ~E~ for vapers and by G ~P~ in those with the smoking predictor.

The illustrative results in [Table 2](#T2){ref-type="table"}, supported by mathematical detail in Additional File 2 ( [@ref-50]), demonstrate the problem. In the basic Situation 1, we set P ~1~ = 0.2, P ~2~ = 0.2, K = 5, P ~A~ = 0.05, G ~E~ = 1, and G ~P~ = 4. Instead of observing the true gateway effect (G ~E~) of 1, we observe a spurious gateway effect of 1.633 due to the uncontrolled confounding. In Situations 2--6, G ~E~ remains at 1, but other parameters are varied. There is a clear tendency for the confounding effect to increase with increasing K (Situation 2) and G ~P~ (Situation 3), but varying P ~A~ (Situation 4), P ~1~ (Situation 5), or P ~2~ (Situation 6) has less effect. Increasing G ~E~, with the other parameters fixed (Situation 7), increases the observed gateway effect, but the ratio of the observed to the true gateway effect is somewhat reduced, from 1.633 for G ~E~ = 1 to 1.352 for G ~E~ = 10.

###### Bias in the gateway effect due to failure to adjust for the smoking predictor.

  -----------------------------------------------------------------------------------------------------------------------------------------------------
  Situation    Proportion of\      Proportion\       Odds ratio\         Probability of smoking\       True OR of\         True\            Observed\
               vapers in never-\   with predictor\   relating vaping\    in non-vapers where the\      smoking for\        gateway\         gateway\
               smokers (P ~1~)     in never-\        and predictor (K)   predictor is absent (P ~A~)   predictor (G ~P~)   effect (G ~E~)   effect
                                   smokers (P ~2~)                                                                                          
  ------------ ------------------- ----------------- ------------------- ----------------------------- ------------------- ---------------- -----------
  1 -- basic   0.2                 0.2               5                   0.05                          4                   1                1.633

  2 (a)        0.2                 0.2               2                   0.05                          4                   1                1.233

  \(b\)                                              3                                                 4                   1                1.399

  \(c\)                                              10                                                4                   1                1.980

  3 (a)        0.2                 0.2               5                   0.05                          2                   1                1.266

  \(b\)                                                                                                7                   1                1.983

  \(c\)                                                                                                10                  1                2.218

  4 (a)        0.2                 0.2               5                   0.02                          4                   1                1.644

  \(b\)                                                                  0.1                           4                   1                1.614

  \(c\)                                                                  0.2                           4                   1                1.573

  5 (a)        0.1                 0.2               5                   0.05                          4                   1                1.658

  \(b\)        0.3                                                                                     4                   1                1.599

  \(c\)        0.5                                                                                     4                   1                1.520

  6 (a)        0.2                 0.1               5                   0.05                          4                   1                1.438

  \(b\)                            0.3                                                                 4                   1                1.666

  \(c\)                            0.5                                                                 4                   1                1.510

  7 (a)        0.2                 0.2               5                   0.05                          4                   2                3.149

  \(b\)                                                                                                4                   4                5.956

  \(c\)                                                                                                4                   10               13.522
  -----------------------------------------------------------------------------------------------------------------------------------------------------

Bias in the estimated gateway effect due to adjustment for an inaccurately measured covariate -- residual confounding
---------------------------------------------------------------------------------------------------------------------

While confounding is well understood by epidemiologists, and is the reason why the authors of the gateway papers made some adjustments, "residual confounding," arising from inaccurately determining confounding variables, is rarely considered. Many statisticians have highlighted this problem of residual confounding. Almost 40 years ago, [@ref-33] noted that "misclassification of a confounder" leads to "partial loss of ability to control confounding," while [@ref-83] later noted that "even misclassification rates as low as 10% can prevent adequate control of confounding." Other publications ( [@ref-2]; [@ref-30]; [@ref-34]; [@ref-65]; [@ref-73]) show that if X is an inaccurately measured true cause of disease, and Y, precisely measured, is not a cause but is correlated with X, one may conclude incorrectly that Y, not X, is the cause. None of the gateway papers cited in [Table 1](#T1){ref-type="table"}, nor [@ref-77], made attempts to adjust for bias from residual confounding, although all except two ( [@ref-69]; [@ref-68]) mention possible bias from incomplete adjustment.

[Table 3](#T3){ref-type="table"} (see also Additional File 2 ( [@ref-50])) gives illustrative examples of the effect of residual confounding. Situations 1 to 4 concern misclassification occurring in each direction, and correspond to situations 1, 2(a), 3(a), and 7(a) in [Table 2](#T2){ref-type="table"}, where no misclassification is assumed. Whereas in [Table 2](#T2){ref-type="table"}, the smoking predictor is assumed to be measured accurately, and adjustment for it would correct the observed gateway effect back to its true value (G ~E~); this is not true when misclassification is present. Thus, in Situation 1, where G ~E~ is set at 1, adjustment for the misclassified predictor does not fully correct for the confounding. Adjustment is useless where the misclassification rate is 50% with the observed gateway effect staying at its unadjusted value of 1.633. With a 10% misclassification rate, the value reduces to 1.281 so that almost half (281/633 = 44.4%) of the spurious increase in the OR remains. As misclassification rates reduce, the adjusted rate approaches its true value.

###### Residual confounding due to misclassification of the smoking predictor.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Situation   Odds ratio\         True OR of smoking\     True RR gateway\   Observed gateway effect                                                               
              relating vaping\    for predictor (G ~P~)   Effect (G ~E~)                                                                                           
              and predictor (K)                                                                                                                                    
  ----------- ------------------- ----------------------- ------------------ --------------------------------------------- ------- ------- ------- ------- ------- -------
                                                                             **Misclassification is in both directions**                                           

  1           5                   4                       1                  1.633                                         1.034   1.067   1.157   1.281   1.455   1.633

  2           2                   4                       1                  1.233                                         1.013   1.026   1.060   1.106   1.169   1.233

  3           5                   2                       1                  1.266                                         1.015   1.029   1.068   1.120   1.193   1.266

  4           5                   4                       2                  3.149                                         2.058   2.115   2.270   2.486   2.802   3.149

                                                                             **Only false positives**                                                              

  5           5                   4                       1                  1.633                                         1.030   1.058   1.136   1.246   1.408   1.625

                                                                             **Only false negatives**                                                              

  6           5                   4                       1                  1.633                                         1.005   1.010   1.028   1.062   1.144   1.414
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Notes: A misclassification rate of x% in both directions (considered in situations 1 to 4) implies that x% of those who have the factor that predicts smoking (e.g. risk takers) are wrongly classified as not having it, and x% of those who do not have the factor are wrongly classified as having it. Situations 5 and 6 consider misclassification in one direction. All models have P ~1~ = P ~2~ = 0.2 and P ~A~ = 0.5.

The pattern is similar in Situations 2 and 3, where G ~E~ remains at 1, but K and R ~P~ are varied. Again, all of the bias remains with 50% misclassification, and almost half remains with 10% misclassification. This is also observed in Situation 4, where G ~E~ = 2. Situations 5 and 6 are similar to Situation 1, except that misclassification is assumed to be unidirectional. The bias is similar to that observed in Situation 1, where only false positives occur (Situation 5), but is less where only false negatives are present (Situation 6). Thus poor specificity is more important than poor sensitivity as a source of bias.

How might smoking prevalence be affected by any true effects of vaping?
-----------------------------------------------------------------------

It is important to understand how vaping might affect the prevalence of cigarette smoking. Not only might there be gateway effects, with vaping increasing the probability of subsequent smoking, but vaping by smokers might also increase their probability of smoking cessation. In an attempt to gain some understanding, we used the second sheet of the Excel program we developed (see also the mathematical details in Additional File 3 ( [@ref-50])). The program considers 10,000 individuals, 2,000 in each of five strata that represent groups with varying smoking susceptibility. All individuals start as never users of either product and over time may switch to become current users of either product only, current dual users, or former users of either or both products (who currently use neither).

Where there is no effect of vaping on initiation or cessation, the user may vary the values of P ~1~, R ~1~, R ~2~, R ~3~ and R ~4~ as defined in the methods section. These parameters are then used to update tobacco use status over time. Where there is an effect of vaping, the user may define G ~1~, the gateway effect, and G ~2~, the effect on the probability of smoking cessation.

[Table 4](#T4){ref-type="table"} presents illustrative examples where G ~1~ and G ~2~ are set at 1.0. The five parameters P ~1~, R ~1~, R ~2~, R ~3~ and R ~4~ are varied in turn, with the others held constant. Increasing e-cigarette initiation rates by increasing P ~1~ (Block 1) reduces never-users, with a compensating increase in dual users and in the odds ratio relating current vaping to current smoking. In Block 1, it is assumed that there is no quitting or re-initiation (R ~3~ = R ~4~ = 0), the relative odds of initiation for successive strata (R ~1~) are set at 5, and the initiation rates are assumed the same for both tobacco products (R ~2~ = 1). Increasing R ~1~ (Block 2), which increases the between stratum variation in smoking susceptibility, markedly increases the odds ratio relating current vaping to current smoking. The other Blocks keep P ~1~ at 0.0002 and R ~1~ at 5. Increasing R ~2~ (Block 3) increases the frequency of smoking relative to vaping, the frequency of dual use and the odds ratio relating current vaping to current smoking. Increasing the quitting factor R ~3~ (Block 4) reduces smokers, but the odds ratio is less affected. Furthermore, increasing the re-initiation factor R ~4~ (Block 5) has little effect; in fact, the chance of someone initiating, quitting, then re-initiating during follow-up is small for the given parameter values.

###### Effect of varying parameters on tobacco use and on the odds ratio relating vaping and smoking.

All models assume G ~1~ and G ~2~ are 1.

  -----------------------------------------------------------------------------------------------------------------------------------------
  Parameters   Percentage distribution of tobacco use   Odds ratio relating\                                                        
                                                        current vaping\                                                             
                                                        and smoking                                                                 
  ------------ ---------------------------------------- ---------------------- ------ ----- ----- ------ ------ ------ ------ ----- -------
  1            0.0001                                   5                      1      0     0     88.0   5.3    5.3    1.4    0.0   4.52

               0.0002                                   5                      1      0     0     80.6   7.6    7.6    4.3    0.0   5.93

               0.0005                                   5                      1      0     0     69.3   9.1    9.1    12.5   0.0   10.44

               0.001                                    5                      1      0     0     60.8   9.2    9.2    20.9   0.0   15.05

               0.002                                    5                      1      0     0     52.1   9.3    9.3    29.4   0.0   17.85

  2            0.0002                                   3                      1      0     0     95.5   2.2    2.2    0.1    0.0   2.67

               0.0002                                   10                     1      0     0     59.2   6.8    6.8    27.2   0.0   34.65

  3            0.0002                                   5                      0.25   0     0     85.6   10.5   2.3    1.3    0.0   4.83

               0.0002                                   5                      0.5    0     0     83.9   9.4    4.3    2.5    0.0   5.19

               0.0002                                   5                      2      0     0     75.7   5.3    12.5   6.5    0.0   7.43

               0.0002                                   5                      4      0     0     69.5   3.2    18.7   8.7    0.0   10.15

  4            0.0002                                   5                      1      0.1   0     80.6   7.5    7.5    4.0    0.4   5.77

               0.0002                                   5                      1      0.2   0     80.6   7.4    7.4    3.9    0.7   5.62

               0.0002                                   5                      1      0.5   0     80.6   6.8    6.8    2.7    1.7   5.25

               0.0002                                   5                      1      1.0   0     80.6   6.8    6.8    2.7    3.2   4.79

  5            0.0002                                   5                      1      0.2   0.1   80.6   7.4    7.4    3.9    0.7   5.61

               0.0002                                   5                      1      0.2   0.2   80.6   7.4    7.4    3.9    0.7   5.60

               0.0002                                   5                      1      0.2   0.5   80.6   7.4    7.5    3.9    0.6   5.58
  -----------------------------------------------------------------------------------------------------------------------------------------

P ~1~, initiation rate of vaping in stratum 1; R ~1~, relative odds of initiation for successive strata; R ~2~, relative odds of initiation for smoking compared to vaping; R ~3~, relative odds of quitting compared to initiation; R ~4~, relative odds of re-initiation compared to initiation.

[Table 5](#T5){ref-type="table"}, [Table 6](#T6){ref-type="table"} and [Table 7](#T7){ref-type="table"} show how the relative odds of smoking are affected by variations, respectively, in G ~1~ only, G ~2~ only, or both. All these results set P ~1~ = 0.0002, R ~1~ = 5, and R ~4~ = 0. With G ~1~ and G ~2~ set at 1.0, there are 11.28% cigarette smokers at the end of follow up: 7.43% smoking cigarettes only, and 3.85% dual users.

###### Effect of varying G ~1~ and R ~2~ on smoking prevalence and the relative odds of smoking.

  ------------------------------------------------
  G ~1~   R ~2~   \% cigarette\   Relative odds\
                  smokers         of smoking
  ------- ------- --------------- ----------------
  1       1       11.28           1 (base)

  2       1       12.31           1.10

  3       1       13.03           1.18

  4       1       13.56           1.23

  5       1       13.93           1.28

  1       0.25    3.56            1 (base)

  5       0.25    5.23            1.50

  1       0.5     6.56            1 (base)

  5       0.5     8.93            1.40

  1       2       17.37           1 (base)

  5       2       19.66           1.16

  1       2       23.22           1 (base)

  5       4       24.79           1.09
  ------------------------------------------------

G ~1~, is the gateway effect; R ~2~, the relative odds of initiation for smoking compared to vaping. The assumed values of the other parameters are P ~1~ = 0.0002, R ~1~ = 5, R ~3~ = 0.2, R ~4~ = 0, and G ~2~ = 1. See text for the full definitions of these other parameters.

###### Effect of varying G ~2~, R ~2~, and R ~3~ on % smokers and relative smoking odds.

Odds are expressed relative to the situation where G ~1~ and G ~2~ = 1.

  -----------------------------------------------------
  G ~2~   R ~2~   R ~3~   \% smokers   Relative odds\
                                       of smoking
  ------- ------- ------- ------------ ----------------
  1       1       0.2     11.28        1 (base)

  2       1       0.2     11.16        0.99

  3       1       0.2     11.06        0.98

  4       1       0.2     10.96        0.97

  5       1       0.2     10.87        0.96

  1       1       0.5     11.28        1 (base)

  5       1       0.5     9.82         0.93

  1       0.25    0.2     3.56         1 (base)

  5       0.25    0.2     3.52         0.99

  1       0.5     0.2     6.56         1 (base)

  5       0.5     0.2     6.42         0.98

  1       2       0.2     17.37        1 (base)

  5       2       0.2     16.40        0.93

  1       4       0.2     23.22        1 (base)

  5       4       0.2     21.55        0.91
  -----------------------------------------------------

G ~2~ is the effect on the probability of smoking cessation. R ~2~ is the relative odds of initiation for smoking compared to vaping. R ~3~ is the relative odds of quitting compared to initiation. The assumed values of the other parameters are P ~1~ = 0.0002, R ~1~ = 5, R ~4~ = 0, and G ~1~ = 1. See text for the definitions of these other parameters.

###### Odds of smoking according to variation in G ~1~, G ~2~, R ~2~, and R ~3~.

               G ~1~   1   1       1       2       2       2       5       5       5
  ------ ----- ------- --- ------- ------- ------- ------- ------- ------- ------- -------
  0.25   0.2           1   0.997   0.989   1.143   1.140   1.129   1.497   1.491   1.473
  0.25   0.5           1   0.993   0.975   1.136   1.128   1.104   1.473   1.459   1.421
  0.5    0.2           1   0.994   0.978   1.129   1.121   1.101   1.398   1.387   1.358
  0.5    0.5           1   0.987   0.955   1.123   1.107   1.066   1.383   1.359   1.301
  1      0.2           1   0.989   0.960   1.104   1.091   1.056   1.276   1.259   1.217
  1      0.5           1   0.976   0.926   1.102   1.073   1.012   1.272   1.236   1.160
  2      0.2           1   0.979   0.933   1.072   1.050   0.999   1.164   1.140   1.086
  2      0.5           1   0.961   0.897   1.073   1.031   0.959   1.169   1.124   1.046
  4      0.2           1   0.967   0.908   1.043   1.011   0.952   1.090   1.059   1.002
  4      0.5           1   0.952   0.890   1.048   0.999   0.936   1.103   1.055   0.990

G ~1~ is the gateway effect. G ~2~ is the effect on the probability of smoking cessation. R ~2~ is the relative odds of initiation for smoking compared to vaping. R ~3~ is the relative odds of quitting compared to initiation. The assumed values of the other parameters are P ~1~ = 0.0002, R ~1~ = 5, and R ~4~ = 0. See text for the definitions of these other parameters.

As G ~1~ increases to 5 ( [Table 5](#T5){ref-type="table"}), the percentage of cigarette smokers rises to 13.96%, giving an OR for smoking of 1.28 compared with G ~1~ = 1. The increase in the percentage of smokers is proportionally much less than the increase in G ~1~. [Table 5](#T5){ref-type="table"} also shows that the gateway effect becomes more important as the relative initiation rate of cigarettes compared with that of e-cigarettes (R ~2~) decreases.

As G ~2~ increases from 1 to 5 ( [Table 6](#T6){ref-type="table"}), the percentage of smokers declines. The effect is less than for increasing G ~1~, and it is in the opposite direction. This effect is increased as R ~3~, the relative frequency of quitting to initiation, is increased. [Table 6](#T6){ref-type="table"} also shows that G ~2~ becomes more important as R ~2~ increases.

In [Table 7](#T7){ref-type="table"}, both G ~1~ and G ~2~ are varied, with the relative odds of smoking shown for combinations of G ~1~ and G ~2~ = 1, 2, or 5 and for varying values of R ~2~ and R ~3~. The highest relative odds of smoking (1.497) are seen for the highest values of G ~1~ and R ~2~ and the lowest values of G ~2~ and R ~3~, while the lowest odds of smoking (0.890) are seen in the reverse situation.

The effects sometimes approximately cancel out. Given R ~3~ \< 1 (and it seems unlikely that quit rates would exceed initiation rates), effects of varying G ~1~ tend to exceed effects of varying G ~2~ where initiation rates are similar for vaping and smoking. However, where initiation rates for smoking are substantially higher (R ~2~ = 4), effects of similar G ~1~ and G ~2~ values also approximately cancel out. Here, with relatively more smokers to quit, effects of varying G ~2~ are more relevant.

While the above results are illustrative, one can derive five main general conclusions from them: 1.Large increases in G ~1~, the gateway effect, result in proportionately much smaller increases in the smoking prevalence.2.Gateway effects increase if initiation with vaping is more frequent than initiation with smoking.3.Increasing G ~2~ decreases smoking prevalence, but less than that from a similar increase in G ~1~.4.Effects of varying G ~2~ increase as R ~2~ and R ~3~ increase, where there are more smokers who can quit.5.With both G ~1~ and G ~2~ \>1, the overall effect on smoking prevalence may be in either direction.

Has introducing e-cigarettes affected smoking trends?
-----------------------------------------------------

Smoking prevalence in U.S. youths had declined substantially even before vaping became popular. For example, the [YRBS](https://www.cdc.gov/healthyyouth/data/yrbs/index.htm) reported a decline in past 30-day smoking from 34.8% in 1995 to 15.7% in 2013. Has introducing e-cigarettes halted or even reversed this decline?

The NYTS is the only U.S. youth survey providing trend data on e-cigarette use over a reasonably long time period. In that survey, the prevalence of past 30-day vaping in each year from 2011--2015 was 1.0%, 2.0%, 2.9%, 9.2%, and 11.1%, respectively, for students in grades 6--12. In 2011--2013, vaping seems too rare to allow for assessment of any effect on smoking prevalence. To detect any effect, it seems more appropriate to compare the prevalence in 2014--2016 with that predicted from pre-existing trends.

[Table 8](#T8){ref-type="table"} presents results from this comparison based on the U.S. NYTS, YRBS, MTF, and NSDUH surveys. All estimates are for past 30-day smoking. In all these surveys, smoking prevalence in 2014--2016 was less than predicted from the underlying trend, contrary to expectations of a definitive gateway effect being present. The tendency for the decline in prevalence to accelerate over 2014--2016 is evident regardless of sex or age. Additional File 4 ( [@ref-50]) provides further detail, including the observed data for the years before 2014, the fitted linear regression of log (p/(1 − p)) on year for years up to 2013, and graphical illustration that this linear regression model fits the data well.

###### Observed smoking percentages in five studies compared to predictions from previous trends ^[a](#FN2){ref-type="other"}^.

  Study ^[b](#FN2){ref-type="other"}^   Age/grade         Observed/predicted   2014    2015    2016
  ------------------------------------- ----------------- -------------------- ------- ------- -------
  NYTS                                  6th--12th grade   Observed             6.2     6.1     \-
                                                          Predicted            8.22    7.77    \-
  MTF                                   8th grade         Observed             4.0     3.6     2.6
                                                          Predicted            4.42    4.07    3.75
  MTF                                   10th grade        Observed             7.2     6.3     4.9
                                                          Predicted            9.56    9.03    8.53
  MTF                                   12th grade        Observed             13.6    11.4    10.5
                                                          Predicted            16.00   15.33   14.68
  YRBS                                  9th--12th grade   Observed             \-      11.8    \-
                                        Males             Predicted            \-      14.58   \-
  YRBS                                  9th--12th grade   Observed             \-      9.7     \-
                                        Females           Predicted            \-      12.86   \-
  NSDUH                                 12--17 years      Observed             5.1     4.6     3.8
                                        Males             Predicted            5.29    4.68    4.14
  NSDUH                                 12--17 years      Observed             4.6     3.8     3.1
                                        Females           Predicted            4.99    4.43    3.94
  ONS                                   16--24 years      Observed             25.2    24.1    17.2
                                        Males             Predicted            23.0    22.7    22.4
  ONS                                   16--24 years      Observed             20.9    22.9    16.0
                                        Females           Predicted            21.3    20.6    20.0

^a^Previous years used for estimation of trend: NYTS: 2004, 2006, 2009, 2011--2013; MTF, ONS: 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013; YRBS: 1995, 1997, 1999, 2001, 2003, 2005, 2007, 2009, 2011, 2013; NSDUH: 2009, 2010, 2011, 2012, 2013. ^b^MTF, Monitoring the Future; NSDUH, National Survey on Drug Use and Health; NYTS, National Youth Tobacco Survey; ONS, Office for National Statistics; YRBS, Youth Risk Behavior Survey.

The Smokefree Youth Survey in Great Britain also reported increasing vaping, with percentages of 4%, 6%, 11%, and 10% each year from 2013--2016, respectively, for 11--18-year-olds. As shown in [Table 8](#T8){ref-type="table"}, ONS data (for an older age group) also show no tendency for a rise in cigarette smoking given increasing vaping. Here, very small annual declines (about 0.3% in males and 0.7% in females) over 2006--2015 were followed by a much larger decline of 7% between 2015 and 2016.

These analyses, though clearly limited by the fact that we do not know what smoking prevalence would have been in the absence of e-cigarettes, do not suggest that introducing e-cigarettes has had any material adverse effect on smoking prevalence trends. If there were any gateway effect, it would be clearly outweighed by other issues, such as vaping providing an alternative to cigarettes for tobacco users, or changes in attitudes to smoking resulting from anti-tobacco prevention measures.

Additional evidence on the likelihood of any marked gateway effect on smoking prevalence
----------------------------------------------------------------------------------------

Some additional evidence highlights the improbability of any substantial gateway effect of vaping on smoking prevalence. Based on the U.S. PATH study, [@ref-64] recently reported that only a small percentage of nonsmokers would be interested in using a hypothetical modified risk tobacco product. While these analyses were based on adults, it was possible to confirm this finding from the publicly available data files for 18--24-year-olds. Thus, the proportion "very or somewhat likely" to use such a product was much lower in those who had never used tobacco (57/1745 = 3.3%) than in those who had ever done so (2375/7282 = 32.7%). This difference was similar in both sexes. Those aged 12--17 years old were also asked in the PATH study if they had seen a tobacco product that claims to be safer than other tobacco products in the past 12 months and their likelihood of using such a product in the next 30 days. Again, the proportion answering "very or somewhat likely" was much lower in tobacco never-users (174/4673 = 3.72%) than in ever-users (264/1565 = 16.87%).

Based on the Canadian COMPASS study, [@ref-3] compared rates of smoking initiation over a two-year follow-up period among a sample of 9,501 students between grades 9 and 11 (cigarette never-smokers), classified at baseline into four groups by current e-cigarette use and susceptibility to smoke and assessed using a three-item validated measure. Though the data in Figure 1 of that paper showed that in both unsusceptible and susceptible never-smokers, rates of smoking initiation were higher in current than noncurrent e-cigarette users, only an estimated 33/2646 = 1.2% of those who had tried smoking during the follow-up period were unsusceptible current e-cigarette users.

While evidence on the reported likelihood of future use of a new product or on susceptibility to smoking is less robust than that based on actual initiation of smoking, the results from these studies are consistent with the conclusion that even when there is some gateway effect, any resulting increase in smoking prevalence would be quite small.

How might any true gateway effect modify the population health impact of introducing e-cigarettes?
--------------------------------------------------------------------------------------------------

It is possible for users of alternative tobacco products to have similar nicotine exposure to that of cigarette smokers but potentially much lower risk of smoking-related diseases (SRD). This is illustrated by the experience and prevalence of Swedish snuff ("snus") use ( [@ref-1]; [@ref-11]; [@ref-8]; [@ref-47]; [@ref-48]). As vaping presents significantly reduced exposure to toxicants and harmful and potentially harmful constituents compared with smoking ( [@ref-61]), it would be expected that any harmful effects would be much lower. This hypothesis was subsequently endorsed by an expert group in 2014 ( [@ref-62]).

This hypothesis is also further supported by various theoretical beneficial and adverse effects of vaping (see [Table 9](#T9){ref-type="table"}). The first major benefit of vaping (B1) concerns individuals who, in the absence of e-cigarettes, would have initiated smoking but instead take up vaping. They should have a much lower risk of SRDs than if they had smoked, given, for example, that the expert panel ( [@ref-62]) estimated that relative to cigarettes, e-cigarettes likely pose a reduction in harm of up to 95%. This likely reduction in risk and harm also applies to benefit B2, where smokers who would otherwise have continued to smoke instead switch to vaping. While the benefits would take longer to emerge, as the adverse effects of past smoking need time to disappear, the reduction in risk associated with a switch to vaping should be a considerable proportion of that associated with quitting smoking. The health benefit would even be greater for established smokers, where vaping helps them quit (B3).

###### Theoretical adverse and beneficial effects of e-cigarettes.

       Effect                                                                        Adverse or beneficial
  ---- ----------------------------------------------------------------------------- -----------------------
  A1   Vaping encourages initiation of smoking (gateway)                             Adverse
  A2   Smokers intending to quit switch to vaping instead                            Adverse
  A3   Smokers vape in addition to their normal cigarette consumption                Adverse
  B1   Individuals who would otherwise have smoked vape instead                      Beneficial
  B2   Smokers who would have continued to smoke switch instead to vaping            Beneficial
  B3   Vaping helps established smokers to quit                                      Beneficial
  B4   Vaping helps established smokers to materially reduce cigarette consumption   Beneficial

Effects A3 and B4 in [Table 9](#T9){ref-type="table"} both relate to those who switch from cigarettes to dual use of cigarettes and e-cigarettes. In theory, adverse effects might arise if smokers vape in addition to their usual cigarette consumption (A3), but this is probably implausible, because most dual users are likely to control their nicotine intake and actually reduce their cigarette consumption (B4), partially replacing cigarettes with e-cigarettes ( [@ref-8]; [@ref-58]; [@ref-59]). Note that we use the word "materially" in the definition of effect B4 as theoretically, an adverse health impact might occur if a very small reduction in cigarettes is counterbalanced by a large increase in use of e-cigarettes.

While smokers intending to quit will do worse if they switch to e-cigarettes than if they had quit (A2), they will still do better than if they had continued to smoke.

Clearly, the greatest adverse effect arises for individuals who otherwise would not have smoked but are encouraged by vaping to do so (A1). However, considering the overall population health impact of this gateway effect, two points require emphasis. First, this is only likely to affect young people. Older people who decided not to start tobacco product use seem unlikely to start vaping, and even if they did so, it would probably be because they believe vaping to be much safer than the smoking they have already rejected ( [@ref-57]; [@ref-67]; [@ref-91]; [@ref-93]). Second, the arguments made earlier suggest that the number of new smokers originating from any true gateway-in effect should be quite low. Any adverse effects resulting from a gateway effect in young people (adverse effect A1) are likely to be outweighed in the general population by beneficial effect B1, as evidenced by the substantial numbers who have vaped but not smoked. The reduction in risk of SRDs for such individuals is likely to be almost as great as any increase resulting from a gateway effect.

Discussion
==========

Our analyses yield some major conclusions: 1.While the consistently increased adjusted gateway effect estimates appear compelling ( [Table 1](#T1){ref-type="table"}), they may be severely biased by ignoring established predictors of smoking initiation and residual confounding -- a true causal effect remains to be demonstrated.2.If a true gateway effect were to exist, it would probably have little effect on smoking prevalence.3.No available evidence exists that increasing e-cigarette use has slowed the decline in smoking prevalence; indeed, the decline appears to have accelerated.

Though some publications have used the evidence for a gateway effect in youths to advocate regulations to curb vaping in the general population ( [@ref-60]; [@ref-69]; [@ref-77]), others suggest that this over-interprets the evidence. [@ref-46] point out the need "to better understand and assess confounding variables" and consider that the prospective studies merely "support that a minority of the relatively small number of e-cigarette triers---who haven't also been experimenting with other tobacco products already---will go on to some experimentation with cigarettes." Also, [@ref-53] present calculations showing that "a strategy of replacing cigarette smoking with vaping would yield substantial life year gains, even under pessimistic assumptions \[. . .\]." Our argument that the gateway estimates are subject to relevant uncontrolled confounding is also supported by publications showing that vaping is associated with many factors associated with smoking ( [@ref-6]; [@ref-37]; [@ref-81]). Unlike the implicit conclusion of the National Academies report ( [@ref-61]), which found that control of confounding in the gateway-in studies has been adequate, our conclusions would suggest otherwise. Our conclusion is consistent with that of a recent publication ( [@ref-24]) which, based on data from the PATH study, found that making extensive adjustment for other risk factors, as well as limited adjustment for inaccuracy in some of these, explained as much as 87% of the observed gateway effect.

Our calculations indicating a lack of effect of e-cigarettes on smoking trends are further supported by [@ref-24], who concluded that "the introduction of e-cigarettes was not associated with a change in the linear decline in cigarette smoking among youth." While studies ( [@ref-58]) have argued against the likely population benefit of e-cigarettes due to their pervasive use among youths and young adults, as we have discussed, these analyses often fail to fully consider the limitations and weaknesses of the current evidence of the associated probabilities of e-cigarette use and cigarette smoking initiation in youths.

While various authors ( [@ref-38]; [@ref-53]; [@ref-62]) estimate that the introduction of e-cigarettes will have a beneficial population health impact, a recent publication [@ref-78] argues the opposite, presenting analyses estimating that "e-cigarette use in 2014 would lead to 1,510,000 years of life lost in the U.S. population." The study reported that the large adverse effects from an estimated 168,000 cigarette never-smokers between 12 and 29 years old initiating cigarette smoking in 2015 and going on to become daily smokers would heavily outweigh the very small beneficial effects from an additional 2,070 current cigarette smoking adults aged 25--69 quitting smoking in 2015 and remaining abstinent for seven or more years.

These analyses have various weaknesses. First, they assume that there is no reduction in risk of SRDs for cigarette smokers who become dual users but do not quit cigarettes. Dual users are likely to reduce cigarette consumption ( [@ref-13]; [@ref-27]; [@ref-28]; [@ref-29]; [@ref-59]) and hence their risk of SRD. Second, their analysis showing large adverse effects in youths relies heavily on the estimate of the gateway effect given by [@ref-77], which may largely result from confounding. Third, their analysis showing very small benefits from increased smoking quit rates in adults depended on an estimate derived from a prior review and meta-analysis by [@ref-44] that estimated the OR of quitting among smokers with an interest in quitting. The estimate, and indeed the whole meta-analysis, has since drawn strong criticism from experts in the field for being inaccurate and misleading ( [@ref-88]).

Some limitations of our work and of the available evidence must be noted. First, many risk factors for smoking initiation are correlated, and had even more been adjusted for, this might not have significantly changed the adjusted effect estimates. Second, while we demonstrate that residual confounding may be important, we have not specifically reviewed evidence on how inaccurately particular risk factors are measured. However, nor has anyone else in this context, as far as we are aware. Third, we have not considered the likely persistence of any true gateway effects. Some youths who initiate tobacco use with vaping may try cigarettes but prefer vaping in the long run. Fourth, our consideration of the possible health effects of introducing e-cigarettes, was not based on rigorous modelling, but was somewhat speculative and based only on general considerations. Fifth, we did not consider evidence ( [@ref-22]; [@ref-51]) that vaping may be associated with heavier smoking, although this association may also be subject to confounding problems. Finally, our evidence on trends is based on data where the prevalence of vaping is little more than 10%. Where vaping is infrequent, any true gateway effect will only slightly increase smoking prevalence, as never smokers who have not vaped will far outweigh those who have. Any gateway effect will be greater if vaping is more common, so it is important to continue to monitor smoking and e-cigarette use trends to provide more conclusive insights.

Conclusions
===========

The existence of any true gateway effect has not been clearly demonstrated, due to limited control for confounding factors. Even if there is an effect, and subsequently, some individuals who otherwise would not have done so start to smoke cigarettes, any effect on smoking prevalence will probably be quite small, and general considerations suggest that any overall population health impact of introducing e-cigarettes is still likely be beneficial.

Data availability
=================

**Additional File 1. Confounding factors considered by studies of vaping as a possible gateway to smoking.** This .docx file lists those factors with published evidence of a relationship with smoking and gives those factors not considered in any of the 15 studies considered in [Table 1](#T1){ref-type="table"}.

**Additional File 2. Estimating the effects of omission of a confounding variable, or misclassification of it, on the association between vaping and subsequent initiation of smoking.** This .docx file presents details of the methodology used.

**Additional File 3. How might the prevalence of smoking be affected by any true gateway effects of vaping?** This .docx file presents details of the methodology used.

**Additional File 4. Comparing smoking prevalence in 2014--2016 with that predicted from preceding years.** For each of the 10 datasets considered in [Table 8](#T8){ref-type="table"}, this .xlsx file gives the model fitted to the prevalence in the years preceding 2014, as well as the observed and predicted prevalence, with graphs illustrating the appropriateness of the model and the tendency for the observed prevalence in 2014--2016 to be lower than predicted.

**Gateway calcs2. This .xlsx file is the Excel program used to produce the results presented in Additional Files 2 and 3.**

All data are available on OSF, DOI: [https://doi.org/10.17605/OSF.IO/Z3ST5](https://dx.doi.org/10.17605/OSF.IO/Z3ST5) ( [@ref-50]).

Data are available under the terms of the [Creative Commons Zero \"No rights reserved\" data waiver](http://creativecommons.org/publicdomain/zero/1.0/) (CC0 1.0 Public domain dedication).

We thank Mrs. Y. Cooper and Mrs. D. Morris for typing various drafts of this paper and assembling relevant literature. We also thank Ms. J. Hamling for assistance in preparing the figures in Additional File 4, as well as reviewers and colleagues for helpful comments and Philip Morris International for financial support.
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Version 1

This ambitious paper by Lee and colleagues seems to have several aims, and I fear that the paper suffers from including them all, rather than separating them out into two or more focused manuscripts.

The authors provide a review of the literature discussing what is currently known about the association between use of combusted and electronic tobacco products, they evaluate the likelihood of electronic products providing a gateway in to smoking based on seemingly informal, qualitative trend analyses, and they provide an important discussion about the potential for residual or otherwise uncontrolled confounding to explain or partially explain associations that have been noted in the literature. They also provide data from a series of simulations. The simulations demonstrate the interdependence among various tobacco use patterns in predicting population harm or benefit resulting from electronic tobacco products.

The most important points from the literature-based sections of the paper are a) the difference between predicted and observed smoking prevalence over time, which should reduce the fear that a large gateway to smoking effect is currently operating; b) the likelihood that misclassification and uncontrolled confounding play a role in the results reported by others, and probably lead to an overestimate of gateway-in effect.

The key findings from the simulations are a bit harder to uncover, due to a lack of detail in the methods section and some glossing over of assumptions. The authors found that a gateway-in effect is unlikely to be large enough to substantially affect population health. This is based on the assumptions that a) the current situation, in which smoking is far more prevalent than electronic cigarette use, will remain stable in at least the short run; b) the current higher likelihood of initiating tobacco use with cigarettes vs electronic products will remain stable in at least the short run; and c) the assumptions that the risks associated with electronic products are understood and are definitely lower than risks associated with smoking. If any of these input assumptions were varied, the simulation results would probably be different, and possibly much different. Some of the authors\' strongest statements are due to differences between relative and absolute effects: Small percentages of a large underlying population (smokers) affect a large number of people, and large percentages of a small underlying population (electronic product users or initiators) affect a small number of people. 

Apart from these conceptual concerns, it would strengthen the paper if the input into the simulations were better defined and justified.

The analyses presented in Table 8 seem to be the most informative of the simulations. Estimating the rate of the combination of smoking OR vaping OR dual use and comparing the prevalence in each year to the prevalence predicted by trends in smoking would give clues about the population level effects of e-products. Has overall use increased or stayed the same?

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
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Dr Sulsky makes three main points:

The paper may be better as multiple focussed manuscripts. We did not attempt this, our main purpose being to cover a range of issues relevant to vaping. Note that two of us also recently published in F1000Research on "Investigating gateway effects using the PATH study".

Some key findings from the simulations are hard to uncover and some assumptions not clearly stated. We made numerous amendments to answer these points.

It would also be useful to study trends in combined prevalence of vaping and/or smoking. As the paper's interest concerns effects of vaping on smoking prevalence, and as interpretation of upward trends in combined use is problematic (they may well reduce risk) we did not change the paper here.
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Version 1

This is an interesting and valuable contribution to the field on the hotly debated topic of whether or not e-cigarettes function as a gateway into subsequent combustible cigarette use. Of particular value here is the analysis of the impact of residual confounding on creating spurious associations in observational studies. However, there are a number of issues in the other analyses I would recommend addressing.

  Abstract: This is currently rather data free. I would suggest including some illustrative results here.Results: Particularly in relation to Tables 5-7, I wonder if it would be possible to condense results somewhat (or to move some of these results into supplementary files). It seems that it is not strictly necessary to include all modelled effects, especially since not all are discussed. This makes this section at times difficult to follow. A better way to structure the Tables might be to link these explicitly to the 5 conclusions presented on pages 9 and 10.Terminology: I am not sure that the term "gateway-out" is helpful. At the very least, it would not represent the only way to construe this concept insofar as it could be argued that in a hypothetical scenario the opposite to the "gateway-in" might be the avoidance of uptake of smoking in the first place (another "gateway-out" not related to smoking cessation where adolescents who would have smoked try an e-cigarette and never start smoking). It might therefore be helpful to clarify the difference between those gateway effects away from smokingChange in smoking trends: I am not entirely convinced by this analysis for a number of reasons. First, very little information is provided about the actual analysis undertaken. I would expect to see fitting parameters for various functions to model trends in smoking prevalence in the period prior to 2014. Are these assumed to be linear, logarithmic, polynomial etc.? More detail is required here. A more appropriate way to analyse the data would be to conduct segmented regression or timeseries analysis. Second, based on the current analysis, the problem (somewhat acknowledged on top of page 11) is that it might still be the case that e-cigarettes functioned as a "gateway in" since we do not know what smoking prevalence would have been in the absence of e-cigarettes (and may have been even lower). I don't think this is likely but this issue should be acknowledged more explicitly, perhaps making it clear that such arguments would require "special pleading", i.e. one would need to postulate additional environmental changes which could explain a continued decrease in smoking prevalence even in the presence of a gateway effect.Second paragraph on page 11 does not seem to add anything (it's not clear how these cognitive measures in PATH relate to actual behaviour and so it's quite weak evidence). Suggest dropping this.Table 9: The counterpart to A3 is not presented, i.e. dual use which results in reduction of combustible cigarettes. If there is a commensurate reduction in cigarette consumption associated with an increase in e-cigarette use (if dual users reduce cigarette consumption sufficiently) there may be beneficial health effects (so perhaps this effect should be added). In fact, perhaps a more nuanced discussion of dual use is needed on page 12, given that it may have both positive and negative effects and encompasses such a wide range of behavioural patterns. Please note that the statement on page 11 "The adverse effect for smokers switching to vaping instead of quitting smoking (A2) is not ideal but would still confer some benefits, given what is known regarding the reduced harm and toxicity of e-cigarettes\" is logically inconsistent. If a smoker intending to quit starts using e-cigarettes instead of quitting, there is no benefit (as e-cigarette use even if less harmful than smoking does not confer any benefit over stopping completely).The discussion on end of page 11 and top of page 12 feels rather qualitative. Either provide more quantitative analysis of modelled impact on health effects or move this to the discussion. You don't really provide any primary data to support your conclusion "Finally, introducing e-cigarettes should lead to a reduced risk of SRD." This is rather speculative at this stage without more rigorous modelling as was done e.g. in the NASEM report.
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Taking Dr Shahab's numbered points: As the paper covers numerous issues and the conclusions are intended to be general, and as abstract length is limited, we left the abstract unaltered.We prefer not to change Tables 5 and 7. They are short and reducing them makes it harder to see effects of variation in the different parameters.We have abandoned the terms gateway-in and gateway-out. Gateway-in is now called the gateway effect, and gateway-out is explained more generally.A new additional file (4) gives fuller detail. The model used -- linear in log (p/(1-p)) - was actually described originally, the additional information suggesting this is a reasonable approach. The discussion has been increased here.Rather than dropping some material in the section "Additional evidence on ...", we prefer adding a paragraph clarifying the data limitations.Table 9 and the related discussion have been amended along the lines suggested.We moved the last two paragraphs of results to the discussion.

[^1]: PNL conceived the paper, developed the analyses reported in Additional Files 2 and 3, and drafted the manuscript. KJC discussed the paper with PNL, searched for relevant literature, checked tables, and commented on drafts. EFA was responsible for the work described in Additional Files 1 and 4, collation of data used in [Table 8](#T8){ref-type="table"}, commented on drafts, and contributed to the writing of the manuscript.
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